0026-895X/03/6405-1199-1209$20.00
Mol Pharmacol 64:1199-1209, 2003
Common Signaling Pathways Link Activation of Murine PAR-1, LPA, and S1P Receptors to Proliferation of Astrocytes
Scott D. Sorensen,
Olivier Nicole,
Richard D. Peavy,
Lisa M. Montoya,
C. Justin Lee,
T. J. Murphy,
Stephen F. Traynelis, and
John R. Hepler
Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia
Receptors for the serine protease thrombin and for lysophospholipids are coupled to G proteins and control a wide range of cellular functions, including mitogenesis. Activators of these receptors are present in blood, and can enter the brain during central nervous system (CNS) injury. Reactive astrogliosis, a prominent component of CNS injury with potentially harmful consequences, may involve proliferation of astrocytes. In this study, we have examined the expression and activation of protease activated receptors (PARs), lysophosphatidic acid (LPA) receptors, and sphingosine-1-phosphate (S1P) receptors on murine astrocytes. We show that activation of these three receptor classes can lead to astrogliosis in vivo and proliferation of astrocytes in vitro. Cultured murine cortical astrocytes express mRNA for multiple receptor subtypes of PAR (PAR-1-4), LPA (LPA-1-3) and S1P (S1P-1, -3, -4, and -5) receptors. Comparison of the intracellular signaling pathways of glial PAR-1, LPA, and S1P receptors indicates that each receptor class activates multiple downstream signaling pathways, including Gq/11-directed inositol lipid/Ca2+ signaling, Gi/o activation of mitogen-activated protein kinases (MAPK) (extracellular signal-regulated kinase 1/2 and stress activated protein kinase/c-jun N-terminal kinase, but not p38), and activation of Rho pathways. Furthermore, activation of these different receptor classes can differentially regulate two transcription factor pathways, serum response element and nuclear factor of activated T cells. Blockade of Gi/o signaling with pertussis toxin, MAPK activation with 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophynyltio)butadiene (U0126), or Rho kinase signaling with R-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexane carboxamide (Y27632) can markedly reduce the proliferative response of glial cells to PAR-1, LPA, or S1P receptor activation, suggesting that each of these pathways is important in coupling of receptor activation to glial proliferation.
Received March 17, 2003;
accepted August 12, 2003
Address correspondence to: Dr. John R. Hepler, Emory University School of Medicine, Department of Pharmacology, Rollins Research Center, 1510 Clifton Road, Atlanta, GA 30322-3090. E-mail: jhepler{at}pharm.emory.edu
This article has been cited by other articles:

|
 |

|
 |
 
T. J. Wilson, K. C. Nannuru, and R. K. Singh
Cathepsin G Recruits Osteoclast Precursors via Proteolytic Activation of Protease-Activated Receptor-1
Cancer Res.,
April 1, 2009;
69(7):
3188 - 3195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Gonzalez-Cabrera, E. Jo, M. G. Sanna, S. Brown, N. Leaf, D. Marsolais, M.-T. Schaeffer, J. Chapman, M. Cameron, M. Guerrero, et al.
Full Pharmacological Efficacy of a Novel S1P1 Agonist That Does Not Require S1P-Like Headgroup Interactions
Mol. Pharmacol.,
November 1, 2008;
74(5):
1308 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-P. Wu, K. Mizugishi, M. Bektas, R. Sandhoff, and R. L. Proia
Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
Hum. Mol. Genet.,
August 1, 2008;
17(15):
2257 - 2264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Mannaioni, A. G. Orr, C. E. Hamill, H. Yuan, K. H. Pedone, K. L. McCoy, R. B. Palmini, C. E. Junge, C. J. Lee, M. Yepes, et al.
Plasmin Potentiates Synaptic N-Methyl-D-aspartate Receptor Function in Hippocampal Neurons through Activation of Protease-activated Receptor-1
J. Biol. Chem.,
July 18, 2008;
283(29):
20600 - 20611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. d. S. e Spohr, J. W. Choi, S. E. Gardell, D. R. Herr, S. K. Rehen, F. C. A. Gomes, and J. Chun
Lysophosphatidic Acid Receptor-dependent Secondary Effects via Astrocytes Promote Neuronal Differentiation
J. Biol. Chem.,
March 21, 2008;
283(12):
7470 - 7479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, E. Guerriero, K. Lathrop, and N. SundarRaj
Rho/ROCK Signaling in Regulation of Corneal Epithelial Cell Cycle Progression
Invest. Ophthalmol. Vis. Sci.,
January 1, 2008;
49(1):
175 - 183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Hoelzinger, T. Demuth, and M. E. Berens
Autocrine Factors That Sustain Glioma Invasion and Paracrine Biology in the Brain Microenvironment
J Natl Cancer Inst,
November 7, 2007;
99(21):
1583 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Kassel, N. A. Schulte, S. M. Parker, A. D. Lanik, and M. L. Toews
Lysophosphatidic Acid Decreases Epidermal Growth Factor Receptor Binding in Airway Epithelial Cells
J. Pharmacol. Exp. Ther.,
October 1, 2007;
323(1):
109 - 118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Citro, S. Malik, E. A. Oestreich, J. Radeff-Huang, G. G. Kelley, A. V. Smrcka, and J. H. Brown
Phospholipase C{varepsilon} is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation
PNAS,
September 25, 2007;
104(39):
15543 - 15548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Hamill, W. M. Caudle, J. R. Richardson, H. Yuan, K. D. Pennell, J. G. Greene, G. W. Miller, and S. F. Traynelis
Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson's Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1
Mol. Pharmacol.,
September 1, 2007;
72(3):
653 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Lee, G. Mannaioni, H. Yuan, D. H. Woo, M. B. Gingrich, and S. F. Traynelis
Astrocytic control of synaptic NMDA receptors
J. Physiol.,
June 15, 2007;
581(3):
1057 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, A. Bialkowska, R. Rusovici, S. Chanchevalap, H. Shim, J. P. Katz, V. W. Yang, and C. C. Yun
Lysophosphatidic Acid Facilitates Proliferation of Colon Cancer Cells via Induction of Kruppel-like Factor 5
J. Biol. Chem.,
May 25, 2007;
282(21):
15541 - 15549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Croft and M. F. Olson
The Rho GTPase Effector ROCK Regulates Cyclin A, Cyclin D1, and p27Kip1 Levels by Distinct Mechanisms
Mol. Cell. Biol.,
June 15, 2006;
26(12):
4612 - 4627.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Nicole, A. Goldshmidt, C. E. Hamill, S. D. Sorensen, A. Sastre, P. Lyuboslavsky, J. R. Hepler, R. J. McKeon, and S. F. Traynelis
Activation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain Injury
J. Neurosci.,
April 27, 2005;
25(17):
4319 - 4329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Itagaki, K. B. Kannan, and C. J. Hauser
Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophils
J. Leukoc. Biol.,
February 1, 2005;
77(2):
181 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Martin, R. Goggel, A.-R. Ressmeyer, and S. Uhlig
Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase
Am J Physiol Lung Cell Mol Physiol,
July 1, 2004;
287(1):
L250 - L257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gruber, B. Kandler, C. Jindra, G. Watzak, and G. Watzek
Dental Pulp Fibroblasts Contain Target Cells for Lysophosphatidic Acid
Journal of Dental Research,
June 1, 2004;
83(6):
491 - 495.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics